Huang Sanping – Trademark Portfolio
Entity Type: 01
Huang Sanping owns a portfolio of 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as JIXIK, MNCFN, NAJOZ, OIAWH, and FUTHRI. Of these, 12 are registered. The portfolio spans 7 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 21 (Housewares). Headquartered in Pu'ning, Guangdong.
Qilin Town,
No.655, Nanpi, Nanpi Village,
Pu'ning, Guangdong 515352 , CN
Showing of trademarks Trademarks
Trademark Classifications
Huang Sanping's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Huang Sanping have?
Huang Sanping has 12 U.S. trademarks filed with the USPTO. Of these, 12 registered.
What trademark classes does Huang Sanping file in?
Huang Sanping files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 21 (Housewares), Class 24 (Fabrics), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Huang Sanping's most well-known trademarks?
Huang Sanping's registered trademark portfolio includes well-known marks such as JIXIK, MNCFN, NAJOZ, OIAWH, and FUTHRI. These are among 12 currently registered trademarks in the portfolio.
What is Huang Sanping's trademark registration success rate?
Huang Sanping has a 100% trademark registration rate, with 12 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.